Skip to main content
Erschienen in: Clinical Rheumatology 2/2017

12.12.2016 | Case Based Review

Neuromyotonia as an unusual neurological complication of primary Sjögren’s syndrome: case report and literature review

verfasst von: Fei Xiao

Erschienen in: Clinical Rheumatology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Primary Sjögren’s syndrome (PSS) is a systemic autoimmune disorder characterized by chronic inflammation of exocrine glands such as the lachrymal and salivary glands, leading to xerophthalmia and xerostomia. Neurological manifestations are sometimes found in patients with PSS. A variety of neurological complications has been reported in patients with PSS, and both the central nervous system (CNS) and peripheral nervous system (PNS) can be involved in PSS. Several forms of neuropathy, including polyneuropathy, cranial neuropathy, and multiple mononeuropathy, are often seen in PSS patients. Herein, we report for the first time typical neuromyotonia (NMT) symptoms appearing in a patient with PSS. Neuromyotonia is a rare disorder caused by the hyperexcitability of peripheral nerves, causing spontaneous and continuous muscle contraction. We provide an overview of the literature relating to neurological involvement in PSS, and the etiology of acquired NMT. We also discuss the existence of contactin-associated protein-like 2 (Caspr2) antibodies in NMT patients.
Literatur
1.
Zurück zum Zitat Mori K, Iijima M, Koike H et al (2005) The wide spectrum of clinical manifestations in Sjögren’s syndrome-associated neuropathy. Brain 128(Pt 11):2518–2534CrossRefPubMed Mori K, Iijima M, Koike H et al (2005) The wide spectrum of clinical manifestations in Sjögren’s syndrome-associated neuropathy. Brain 128(Pt 11):2518–2534CrossRefPubMed
2.
Zurück zum Zitat Delalande S, de Seze J, Fauchais AL et al (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83:280–291CrossRef Delalande S, de Seze J, Fauchais AL et al (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83:280–291CrossRef
3.
Zurück zum Zitat Mellgren SI, Göransson LG, Omdal R (2007) Primary Sjögren’s syndrome associated neuropathy. Can J Neurol Sci 34(3):280–287CrossRefPubMed Mellgren SI, Göransson LG, Omdal R (2007) Primary Sjögren’s syndrome associated neuropathy. Can J Neurol Sci 34(3):280–287CrossRefPubMed
4.
Zurück zum Zitat Gono T, Kawaguchi Y, Katsumata Y et al (2011) Clinical manifestations of neurological involvement in primary Sjögren’s syndrome. Clin Rheumatol 30(4):485–490CrossRefPubMed Gono T, Kawaguchi Y, Katsumata Y et al (2011) Clinical manifestations of neurological involvement in primary Sjögren’s syndrome. Clin Rheumatol 30(4):485–490CrossRefPubMed
5.
Zurück zum Zitat Chai J, Logigian EL (2010) Neurological manifestations of primary Sjogren’s syndrome. Curr Opin Neurol 23(5):509–513CrossRefPubMed Chai J, Logigian EL (2010) Neurological manifestations of primary Sjogren’s syndrome. Curr Opin Neurol 23(5):509–513CrossRefPubMed
6.
Zurück zum Zitat Griffin J, Cornblath D, Alexander E et al (1990) Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren’s syndrome. Ann Neurol 27(3):304–315CrossRefPubMed Griffin J, Cornblath D, Alexander E et al (1990) Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren’s syndrome. Ann Neurol 27(3):304–315CrossRefPubMed
7.
Zurück zum Zitat Alexander E, Ranzenbach M, Kumar A et al (1994) Anti-Ro (SS-A) autoantibodies in central nervous system disease associated with Sjögren’s syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates. Neurology 44(5):899–908CrossRefPubMed Alexander E, Ranzenbach M, Kumar A et al (1994) Anti-Ro (SS-A) autoantibodies in central nervous system disease associated with Sjögren’s syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates. Neurology 44(5):899–908CrossRefPubMed
8.
Zurück zum Zitat Mellgren S, Conn D, Stevens J, Dyck P (1989) Peripheral neuropathy in primary Sjögren’s syndrome. Neurology 39(3):390–394CrossRefPubMed Mellgren S, Conn D, Stevens J, Dyck P (1989) Peripheral neuropathy in primary Sjögren’s syndrome. Neurology 39(3):390–394CrossRefPubMed
9.
Zurück zum Zitat Lecky B, Hughes R, Murray N (1987) Trigeminal sensory neuropathy. A study of 22 cases. Brain 110(Pt 6):1463–1485CrossRefPubMed Lecky B, Hughes R, Murray N (1987) Trigeminal sensory neuropathy. A study of 22 cases. Brain 110(Pt 6):1463–1485CrossRefPubMed
10.
Zurück zum Zitat Satake M, Yoshimura T, Iwaki T, Yamada T, Kobayashi T (1995) Anti-dorsal root ganglion neuron antibody in a case of dorsal root ganglionitis associated with Sjögren’s syndrome. J Neurol Sci 132(2):122–125CrossRefPubMed Satake M, Yoshimura T, Iwaki T, Yamada T, Kobayashi T (1995) Anti-dorsal root ganglion neuron antibody in a case of dorsal root ganglionitis associated with Sjögren’s syndrome. J Neurol Sci 132(2):122–125CrossRefPubMed
13.
Zurück zum Zitat Deymeer F, Oge AE, Serdaroglu P, Yazici J, Ozdemir C, Baslo A (1998) The use of botulinum toxin in localizing neuromyotonia to the terminal branches of the peripheral nerve. Muscle Nerve 21:643–646CrossRefPubMed Deymeer F, Oge AE, Serdaroglu P, Yazici J, Ozdemir C, Baslo A (1998) The use of botulinum toxin in localizing neuromyotonia to the terminal branches of the peripheral nerve. Muscle Nerve 21:643–646CrossRefPubMed
14.
15.
Zurück zum Zitat Garcia-Merino A, Cabello A, Mora JS, Liaño H (1991) Continuous muscle fiber activity, peripheral neuropathy, and thymoma [see comments]. Ann Neurol 29:215–218 Comment in: Ann Neurol 1991;30:735–6CrossRefPubMed Garcia-Merino A, Cabello A, Mora JS, Liaño H (1991) Continuous muscle fiber activity, peripheral neuropathy, and thymoma [see comments]. Ann Neurol 29:215–218 Comment in: Ann Neurol 1991;30:735–6CrossRefPubMed
16.
Zurück zum Zitat Sigwald J, Raverdy P, Fardeau M et al (1966) Rev Neurol (Paris) 115:1003–1014 Sigwald J, Raverdy P, Fardeau M et al (1966) Rev Neurol (Paris) 115:1003–1014
17.
Zurück zum Zitat Martinelli P, Patuelli A, Minardi C, Cau A, Riviera AM, Dal Pozzo F (1996) Neuromyotonia, peripheral neuropathy and myasthenia gravis. Muscle Nerve 19:505–510CrossRefPubMed Martinelli P, Patuelli A, Minardi C, Cau A, Riviera AM, Dal Pozzo F (1996) Neuromyotonia, peripheral neuropathy and myasthenia gravis. Muscle Nerve 19:505–510CrossRefPubMed
18.
Zurück zum Zitat Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR (2002) Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125:1887–1895CrossRefPubMed Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR (2002) Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125:1887–1895CrossRefPubMed
19.
Zurück zum Zitat Irani SR, Vincent A (2016) Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes. Handb Clin Neurol 133:185–197CrossRefPubMed Irani SR, Vincent A (2016) Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes. Handb Clin Neurol 133:185–197CrossRefPubMed
20.
Zurück zum Zitat Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133(9):2734–2748CrossRefPubMedPubMedCentral Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133(9):2734–2748CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Lancaster E, Huijbers MG, Bar V et al (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69(2):303–311CrossRefPubMedPubMedCentral Lancaster E, Huijbers MG, Bar V et al (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69(2):303–311CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat van Sonderen A, Ariño H, Petit-Pedrol M et al (2016) The clinical spectrum of Caspr2 antibody-associated disease. Neurology 87(5):521–528CrossRefPubMed van Sonderen A, Ariño H, Petit-Pedrol M et al (2016) The clinical spectrum of Caspr2 antibody-associated disease. Neurology 87(5):521–528CrossRefPubMed
Metadaten
Titel
Neuromyotonia as an unusual neurological complication of primary Sjögren’s syndrome: case report and literature review
verfasst von
Fei Xiao
Publikationsdatum
12.12.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 2/2017
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3499-z

Weitere Artikel der Ausgabe 2/2017

Clinical Rheumatology 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.